Exact Mass: 1103.6769528

Exact Mass Matches: 1103.6769528

Found 14 metabolites which its exact mass value is equals to given mass value 1103.6769528, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

CDP-DG(18:2(9Z,11Z)/a-25:0)

{[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(22-methyltetracosanoyl)oxy]-3-[(9Z,11Z)-octadeca-9,11-dienoyloxy]propoxy]phosphoryl}oxy)phosphinic acid

C55H99N3O15P2 (1103.6551084)


CDP-DG(18:2(9Z,11Z)/a-25:0) is a cytidine diphosphate diacylglycerol or CDP-diacylglycerol (CDP-DG). CDP-diacylglycerol is an important branchpoint intermediate in eukaryotic phospholipid biosynthesis and could be a key regulatory molecule in phospholipid metabolism. It is a glycerophospholipid in which a cytidine diphosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, CDP-diacylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. CDP-DG(18:2(9Z,11Z)/a-25:0), in particular, consists of one chain of (9Z,11Z)-octadecadienoic acid at the C-1 position and one chain of anteisopentacosanoic acid at the C-2 position. Cytidine diphosphate diacylglycerols are rarely noticed in analyses of lipid compositions of tissues, as they are present is such small amounts (perhaps only 0.05\\% or so of the total phospholipids).

   

CDP-DG(a-25:0/18:2(9Z,11Z))

{[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(22-methyltetracosanoyl)oxy]-2-[(9Z,11Z)-octadeca-9,11-dienoyloxy]propoxy]phosphoryl}oxy)phosphinic acid

C55H99N3O15P2 (1103.6551084)


CDP-DG(a-25:0/18:2(9Z,11Z)) is a cytidine diphosphate diacylglycerol or CDP-diacylglycerol (CDP-DG). CDP-diacylglycerol is an important branchpoint intermediate in eukaryotic phospholipid biosynthesis and could be a key regulatory molecule in phospholipid metabolism. It is a glycerophospholipid in which a cytidine diphosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, CDP-diacylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. CDP-DG(a-25:0/18:2(9Z,11Z)), in particular, consists of one chain of anteisopentacosanoic acid at the C-1 position and one chain of (9Z,11Z)-octadecadienoic acid at the C-2 position. Cytidine diphosphate diacylglycerols are rarely noticed in analyses of lipid compositions of tissues, as they are present is such small amounts (perhaps only 0.05\\% or so of the total phospholipids).

   
   
   

[(2S,3S,4R)-2-[[(2S,3R)-2,3-dihydroxytetracosanoyl]amino]-3,4-dihydroxyoctadecyl] [(1R,2R,3R,4R,5S,6R)-2,3,4,5-tetrahydroxy-6-[(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexyl] hydrogen phosphate

[(2S,3S,4R)-2-[[(2S,3R)-2,3-dihydroxytetracosanoyl]amino]-3,4-dihydroxyoctadecyl] [(1R,2R,3R,4R,5S,6R)-2,3,4,5-tetrahydroxy-6-[(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexyl] hydrogen phosphate

C54H106NO19P (1103.7096296)


   

Man-beta1-2-Ins-1-P-Cer(t18:0/2,3-OH-24:0)

Man-beta1-2-Ins-1-P-Cer(t18:0/2,3-OH-24:0)

C54H106NO19P (1103.7096296)


   

(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxypentadeca-4,8,12-trien-2-yl]hexacosa-5,8,11,14,17,20,23-heptaenamide

(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxypentadeca-4,8,12-trien-2-yl]hexacosa-5,8,11,14,17,20,23-heptaenamide

C59H93NO18 (1103.6392318)


   

(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxynon-4-en-2-yl]dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide

(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxynon-4-en-2-yl]dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide

C59H93NO18 (1103.6392318)


   

Man-beta1-6-Ins-1-P-Cer(t18:0/2,3-OH-24:0)

Man-beta1-6-Ins-1-P-Cer(t18:0/2,3-OH-24:0)

C54H106NO19P (1103.7096296)


A mannosylated ceramide phosphoinositol compound having a tetracosanoyl group attached to the ceramide nitrogen, hydroxylation at C-4 of the long-chain base, and hydroxylation at C-2 and C-3 of the very-long-chain fatty acid.

   

(3s,6s,9r,12s,14r,15r,16s,17e,19e,22s,25s)-22-[(2e,4e,8s,9s)-10-[(2s,3r,4s,5s,6r,9s,11s)-9-ethyl-4,8-dihydroxy-3,5,11-trimethyl-1-oxa-7-azaspiro[5.5]undec-7-en-2-yl]-9-hydroxy-8-methyldeca-2,4-dien-2-yl]-5,8,16-trihydroxy-3-[(3-hydroxyphenyl)methyl]-6-isopropyl-12-methoxy-12,15-dimethyl-13,23-dioxa-1,4,7,29-tetraazatricyclo[23.3.1.0⁹,¹⁴]nonacosa-4,7,17,19-tetraene-2,24-dione

(3s,6s,9r,12s,14r,15r,16s,17e,19e,22s,25s)-22-[(2e,4e,8s,9s)-10-[(2s,3r,4s,5s,6r,9s,11s)-9-ethyl-4,8-dihydroxy-3,5,11-trimethyl-1-oxa-7-azaspiro[5.5]undec-7-en-2-yl]-9-hydroxy-8-methyldeca-2,4-dien-2-yl]-5,8,16-trihydroxy-3-[(3-hydroxyphenyl)methyl]-6-isopropyl-12-methoxy-12,15-dimethyl-13,23-dioxa-1,4,7,29-tetraazatricyclo[23.3.1.0⁹,¹⁴]nonacosa-4,7,17,19-tetraene-2,24-dione

C61H93N5O13 (1103.6769528)


   

(3s,6s,9r,12s,14r,15s,16s,17e,19e,22s,25s)-22-[(2e,4e,8s,9s)-10-[(2s,3r,4s,5s,6r,9s,11s)-9-ethyl-4,8-dihydroxy-3,5,11-trimethyl-1-oxa-7-azaspiro[5.5]undec-7-en-2-yl]-9-hydroxy-8-methyldeca-2,4-dien-2-yl]-5,8,16-trihydroxy-3-[(3-hydroxyphenyl)methyl]-6-isopropyl-12-methoxy-12,15-dimethyl-13,23-dioxa-1,4,7,29-tetraazatricyclo[23.3.1.0⁹,¹⁴]nonacosa-4,7,17,19-tetraene-2,24-dione

(3s,6s,9r,12s,14r,15s,16s,17e,19e,22s,25s)-22-[(2e,4e,8s,9s)-10-[(2s,3r,4s,5s,6r,9s,11s)-9-ethyl-4,8-dihydroxy-3,5,11-trimethyl-1-oxa-7-azaspiro[5.5]undec-7-en-2-yl]-9-hydroxy-8-methyldeca-2,4-dien-2-yl]-5,8,16-trihydroxy-3-[(3-hydroxyphenyl)methyl]-6-isopropyl-12-methoxy-12,15-dimethyl-13,23-dioxa-1,4,7,29-tetraazatricyclo[23.3.1.0⁹,¹⁴]nonacosa-4,7,17,19-tetraene-2,24-dione

C61H93N5O13 (1103.6769528)


   

(3s,6s,9r,12s,14r,15s,16s,17e,19e,22s)-22-[(2e,4e,8s,9s)-10-[(2s,3r,4s,5s,6r,9s,11s)-9-ethyl-4,8-dihydroxy-3,5,11-trimethyl-1-oxa-7-azaspiro[5.5]undec-7-en-2-yl]-9-hydroxy-8-methyldeca-2,4-dien-2-yl]-5,8,16-trihydroxy-3-[(3-hydroxyphenyl)methyl]-6-isopropyl-12-methoxy-12,15-dimethyl-13,23-dioxa-1,4,7,29-tetraazatricyclo[23.3.1.0⁹,¹⁴]nonacosa-4,7,17,19-tetraene-2,24-dione

(3s,6s,9r,12s,14r,15s,16s,17e,19e,22s)-22-[(2e,4e,8s,9s)-10-[(2s,3r,4s,5s,6r,9s,11s)-9-ethyl-4,8-dihydroxy-3,5,11-trimethyl-1-oxa-7-azaspiro[5.5]undec-7-en-2-yl]-9-hydroxy-8-methyldeca-2,4-dien-2-yl]-5,8,16-trihydroxy-3-[(3-hydroxyphenyl)methyl]-6-isopropyl-12-methoxy-12,15-dimethyl-13,23-dioxa-1,4,7,29-tetraazatricyclo[23.3.1.0⁹,¹⁴]nonacosa-4,7,17,19-tetraene-2,24-dione

C61H93N5O13 (1103.6769528)


   

22-(10-{9-ethyl-4,8-dihydroxy-3,5,11-trimethyl-1-oxa-7-azaspiro[5.5]undec-7-en-2-yl}-9-hydroxy-8-methyldeca-2,4-dien-2-yl)-5,8,16-trihydroxy-3-[(3-hydroxyphenyl)methyl]-6-isopropyl-12-methoxy-12,15-dimethyl-13,23-dioxa-1,4,7,29-tetraazatricyclo[23.3.1.0⁹,¹⁴]nonacosa-4,7,17,19-tetraene-2,24-dione

22-(10-{9-ethyl-4,8-dihydroxy-3,5,11-trimethyl-1-oxa-7-azaspiro[5.5]undec-7-en-2-yl}-9-hydroxy-8-methyldeca-2,4-dien-2-yl)-5,8,16-trihydroxy-3-[(3-hydroxyphenyl)methyl]-6-isopropyl-12-methoxy-12,15-dimethyl-13,23-dioxa-1,4,7,29-tetraazatricyclo[23.3.1.0⁹,¹⁴]nonacosa-4,7,17,19-tetraene-2,24-dione

C61H93N5O13 (1103.6769528)


   

3-oxo-3-({5,7,9,11,23,25,27,31,33,34,35-undecahydroxy-10,14,18,22,26,30-hexamethyl-15-[10-(n'-methylcarbamimidamido)decan-2-yl]-17-oxo-16,37-dioxabicyclo[31.3.1]heptatriaconta-12,18-dien-3-yl}oxy)propanoic acid

3-oxo-3-({5,7,9,11,23,25,27,31,33,34,35-undecahydroxy-10,14,18,22,26,30-hexamethyl-15-[10-(n'-methylcarbamimidamido)decan-2-yl]-17-oxo-16,37-dioxabicyclo[31.3.1]heptatriaconta-12,18-dien-3-yl}oxy)propanoic acid

C56H101N3O18 (1103.7079766)